[The modification of experimental bone marrow fibrosis after repeated administration of foreign proteins by antiphlogistics and prednisolone acetate].
D000707:Anaphylaxis / Q000401:mortality; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001772:Blood Cell Count; D001792:Blood Platelets; D001835:Body Weight; D001855:Bone Marrow Diseases / Q000517:prevention & control*; D001856:Bone Marrow Examination; D005357:Fibrous Dysplasia of Bone / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control; D006452:Hemoglobinometry; D007958:Leukocyte Count; D008099:Liver / Q000473:pathology; D010047:Ovalbumin; D010113:Oxyphenbutazone / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology; D011817:Rabbits; D012156:Reticulocytes; D013154:Spleen / Q000473:pathology
D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D010047:Ovalbumin; D011239:Prednisolone; D010653:Phenylbutazone; D010113:Oxyphenbutazone
Die medikamentöse Beeinflussung experimenteller Knochenmarksfibrosen nach wiederholter Fremdeiweiss-Applikation durch Antiphlogistica und Prednisolon-Acetat.